GrowGeneration Joins the U.S. Cannabis Roundtable to Help Shape the Future of America’s Cannabis Industry

Rhea-AI Summary

GrowGeneration (NASDAQ: GRWG), a major supplier to controlled environment agriculture and cannabis cultivators, announced it has joined the U.S. Cannabis Roundtable (USCR), a leading federal cannabis policy organization. CEO and Co-Founder Darren Lampert will represent the company as USCR advocates for reform and standardized regulation.

GrowGeneration highlights the move of state-licensed medical cannabis to Schedule III and potential 280E tax relief as a tailwind that may boost customers’ ability to invest in its cultivation infrastructure.

News Market Reaction – GRWG

-0.67%

-0.67% Session close to close

In the Jul 7 session, GRWG declined 0.67%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

GrowGeneration’s entry into the U.S. Cannabis Roundtable highlights a push into federal policy advoc...

Analysis

GrowGeneration’s entry into the U.S. Cannabis Roundtable highlights a push into federal policy advocacy as medical cannabis shifts to Schedule III and potential 280E tax relief emerges, a backdrop that could influence customers’ cultivation investment decisions.

Key Figures

Legal cannabis states: 41 states

1 metrics

Legal cannabis states 41 states States where cannabis is legal for medical or adult use per USCR members’ operations

Historical Context

5 past events · Latest: May 27 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 27	Conference participation	Neutral	+0.6%	Announcement of participation in Oppenheimer virtual consumer growth and e-commerce conference.
May 12	Earnings results	Positive	+17.5%	Q1 2026 sales growth, narrower net loss, and reaffirmed full‑year guidance.
Apr 30	Earnings call scheduling	Neutral	+3.1%	Scheduled date and time for Q1 2026 earnings release and conference call.
Apr 28	Conference participation	Neutral	-2.9%	Participation in IgniteIt Spotlight: Ohio Valley supply chain panel and meetings.
Mar 24	Product launch	Positive	-1.7%	Launch of Char Coir Propagation System with new trays for early plant development.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has usually produced modest single-day moves, with the latest earnings report generating the only double‑digit reaction.

Key Terms

controlled environment agriculture, schedule iii, controlled substances act, 280e tax

4 terms

controlled environment agriculture technical

"one of the nation’s largest suppliers of specialty products for controlled environment agriculture"

Controlled environment agriculture is the practice of growing fruits, vegetables or herbs inside purpose-built spaces—such as greenhouses or indoor farms—where light, temperature, humidity and water are tightly managed to produce consistent crops year-round. Investors watch it because it turns farming into a predictable, scalable operation (like a factory for plants), affecting yields, costs, supply reliability and price stability, and therefore the revenue and risk profile of businesses involved.

schedule iii regulatory

"moving state-licensed medical cannabis to Schedule III of the Controlled Substances Act"

A Schedule III classification is a regulatory category for drugs and substances that have a recognized medical use but a moderate risk of dependence or abuse, placing them between higher-risk controlled drugs and over-the-counter medicines. For investors, this matters because it shapes how a product can be manufactured, prescribed, marketed and distributed — affecting potential sales, regulatory hurdles, labeling requirements and legal exposure in the market; think of it as a middle level of control that influences commercial access and compliance costs.

controlled substances act regulatory

"moving state-licensed medical cannabis to Schedule III of the Controlled Substances Act"

A federal law that creates the rules for which drugs and chemicals are legal, how they are classified by risk, and what licenses and controls are required for manufacture, distribution, research, and medical use. For investors, these classifications act like traffic signals — they determine how easy or hard it is for companies to develop, sell, or research certain medications and can sharply affect a company’s regulatory cost, market access, and legal risk.

280e tax regulatory

"providing potential 280E tax relief to qualifying operators"

Section 280E of the U.S. tax code prevents businesses involved in trafficking controlled substances from claiming ordinary business deductions and most tax credits on their federal returns, allowing only the direct cost of goods sold to be deducted. For investors this raises the company’s effective tax rate and reduces reported profits and cash flow—similar to running a store that must pay rent and wages without being able to deduct those expenses—affecting valuations and financial comparisons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Brings Valuable Agricultural Expertise to Drive Cannabis Policy Advocacy at the Federal Level

DENVER, Colo., July 07, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers, today announced its membership in the U.S. Cannabis Roundtable (USCR), one of the nation’s leading policy organizations shaping the future of cannabis regulation. GrowGeneration will be represented in USCR by its Chief Executive Officer and Co-Founder, Darren Lampert.

The U.S. Cannabis Roundtable is among the leading voices in federal cannabis reform, bringing together operators, ancillary service providers, and policy experts to advocate for responsible regulation, financial access, and industry standardization. Its members include the nation’s leading cannabis operators and ancillary businesses and operate in all 41 states where cannabis is legal (medical or adult use).

“We're pleased to welcome GrowGeneration as the newest member of USCR,” said Charlie Bachtell, CEO of Cresco Labs and Chairperson of USCR. “With expertise across both agriculture and cannabis, they are uniquely positioned to complement our members' knowledge and experience. We're looking forward to their contributions as we continue to advocate for commonsense industry regulations.”

“We are honored to join USCR and look forward to working with other industry thought leaders during this pivotal time,” said Mr. Lampert. “The order moving state-licensed medical cannabis to Schedule III of the Controlled Substances Act is a landmark event, providing potential 280E tax relief to qualifying operators. This is a meaningful tailwind for our customers, increasing their capacity to invest in the cultivation infrastructure we provide. We believe GrowGeneration is well positioned to support our customers as the industry continues to mature and evolve.”

About GrowGeneration Corp:

GrowGen is one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and garden centers. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Char Coir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, and a benching, racking, and storage solutions business, MMI Storage Solutions.

To be added to the GrowGeneration email distribution list, please email GrowGen@kcsa.com with GRWG in the subject line.

Forward Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the Company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as “look forward,” “expect,” “believe,” “anticipate,” “estimate,” or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: www.sec.gov, and on the Company’s website, at: www.growgeneration.com.

Investor Relations:
KCSA Strategic Communications
Philip Carlson, Managing Director
T: 212-896-1233
GrowGen@KCSA.com

FAQ

What did GrowGeneration (NASDAQ: GRWG) announce on July 7, 2026 regarding the U.S. Cannabis Roundtable?

GrowGeneration announced it has joined the U.S. Cannabis Roundtable (USCR) on July 7, 2026. According to GrowGeneration, membership aligns the company with a leading federal cannabis policy group focused on regulation, financial access, and industry standards across legal U.S. cannabis markets.

How will GrowGeneration (GRWG) participate in the U.S. Cannabis Roundtable?

GrowGeneration will be represented in the U.S. Cannabis Roundtable by CEO and Co-Founder Darren Lampert. According to GrowGeneration, Lampert will contribute the company’s agricultural and cannabis expertise to advocacy efforts around responsible federal regulation, financial access, and standardized policies for industry participants.

How could the move of medical cannabis to Schedule III affect GrowGeneration (GRWG) customers?

GrowGeneration links the move of state-licensed medical cannabis to Schedule III with potential 280E tax relief for operators. According to GrowGeneration, this change may give qualifying customers more financial capacity to invest in cultivation infrastructure and controlled environment agriculture products supplied by the company.

Why does GrowGeneration (GRWG) view potential 280E tax relief as a tailwind for its business?

GrowGeneration describes potential 280E tax relief from Schedule III reclassification as a meaningful tailwind for its customers. According to GrowGeneration, reduced tax burdens could increase operators’ ability to allocate capital toward upgrading and expanding cultivation infrastructure purchased from the company.

What is the U.S. Cannabis Roundtable and why is GrowGeneration (GRWG) joining?

The U.S. Cannabis Roundtable is a policy organization advocating federal cannabis reform, responsible regulation, and financial access. According to GrowGeneration, joining USCR lets the company help shape nationwide cannabis standards while leveraging its agricultural expertise alongside major cannabis operators and ancillary businesses.

How does GrowGeneration’s agricultural expertise support its role in the U.S. Cannabis Roundtable?

GrowGeneration brings experience in controlled environment agriculture, commercial cultivation, and garden centers to the U.S. Cannabis Roundtable. According to GrowGeneration, this agricultural background complements existing member knowledge and is expected to inform discussions on practical, scalable cultivation and infrastructure standards for legal cannabis markets.